Back to Boston Partners Boston Partners

CVSCVS
31 quarters

Position history for Boston PartnersBoston Partners's holdings in CVS HEALTH CORP

Yes. Boston Partners holds 2,033,583 shares of CVS (CVS Health), worth $210.4M, as of its Q2 2026 13F filing. It increased the position from 107,973 shares in Q1 2026. Boston Partners has held CVS since Q2 2025, across 5 quarterly 13F filings. CVS is 0.2% of Boston Partners' reported 13F portfolio.

Current Value

$210.4M

Current Shares

2M

Total Value Change

-$600.9M

Total Shares Change

-10.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+1783.4%
$210.4M0.2%$102.08
59
2026-Q1
Decreased
107,973
-10.9%
$7.8M0.0%$70.25
0
2025-Q4
Increased
121,201
+16.0%
$9.6M0.0%$77.00
32
2025-Q3
Increased
104,491
+116.8%
$7M0.0%$72.55
44
2025-Q2
New
48,195
-
$2.8M0.0%$65.67
36
2025-Q1
Exited
0
-100.0%
$00.0%$63.84
0
2024-Q4
Decreased
6,669
-9.8%
$299,3700.0%$41.77
0
2024-Q3
Decreased
7,391
-0.8%
$464,7490.0%$57.86
0
2024-Q2
Decreased
7,448
-77.5%
$439,8780.0%$53.74
0
2024-Q1
Decreased
33,095
-37.5%
$2.6M0.0%$71.88
0
2023-Q4
Decreased
52,968
-31.4%
$4.2M0.0%$70.52
0
2023-Q3
Decreased
77,179
-98.8%
$5.4M0.0%$61.82
0
2023-Q2
Decreased
6.5M
-8.1%
$453.8M0.6%$60.71
0
2023-Q1
Decreased
7.1M
-18.1%
$529.4M0.7%$64.73
0
2022-Q4
Increased
8.7M
+8.3%
$809.1M1.1%$80.62
54
2022-Q3
Increased
8M
+15.5%
$766.8M1.1%$82.01
57
2022-Q2
Increased
7M
+3.0%
$645.5M0.9%$79.22
46
2022-Q1
Increased
6.8M
+1.1%
$684.3M0.8%$86.08
45
2021-Q4
Increased
6.7M
+39.6%
$689.7M0.8%$87.28
59
2021-Q3
Increased
4.8M
+5.1%
$406.5M0.5%$71.38
46
2021-Q2
Increased
4.6M
+26.2%
$380.2M0.5%$69.76
46
2021-Q1
Decreased
3.6M
-1.9%
$271.7M0.4%$62.49
0
2020-Q4
Increased
3.7M
+259.0%
$251.4M0.4%$56.36
59
2020-Q3
Decreased
1M
-13.4%
$59.9M0.1%$47.78
0
2020-Q2
Decreased
1.2M
-10.8%
$76.9M0.1%$52.74
0
2020-Q1
Decreased
1.3M
-82.6%
$78.7M0.2%$47.77
0
2019-Q4
Decreased
7.6M
-7.5%
$566.3M0.7%$59.41
0
2019-Q3
Decreased
8.2M
-5.8%
$519.7M0.7%$50.06
0
2019-Q2
Decreased
8.7M
-14.9%
$476.4M0.6%$42.86
0
2019-Q1
Decreased
10.3M
-17.1%
$553.6M0.7%$42.02
0
2018-Q4
First report
12.4M
-
$811.3M1.2%$50.66
0

Other major holders of CVS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used